查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1933954

聚焦超音波消融手术市场：按技术、工作流程、系统类型、患者年龄层、应用和最终用户划分－全球预测，2026-2032年

Focused Ultrasound Ablation Surgery Market by Technology, Workflow, System Type, Patient Age Group, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，聚焦超音波消融手术市场价值将达到 30.1 亿美元，到 2026 年将成长至 32.6 亿美元，到 2032 年将达到 58.1 亿美元，复合年增长率为 9.84%。

关键市场统计数据
基准年 2025 30.1亿美元
预计年份：2026年 32.6亿美元
预测年份 2032 58.1亿美元
复合年增长率 (%) 9.84%

影像引导能量传输和不断发展的临床通讯协定如何改变聚焦超音波消融术在专科领域的应用路径

聚焦超音波消融术已从一项实验性介入措施发展成为多个临床专科的主流治疗方法。该技术结合了精确的能量传递和影像引导，可实现非侵入性或微创组织消融，在减少手术全期併发症、缩短恢復时间和建立门诊治疗路径方面展现出良好的临床应用前景。在神经病学领域，热消融和神经调控方法正不断改进，以毫米级的精度靶向深部脑部结构，用于治疗运动障碍和难治性癫痫。在肿瘤学领域，热消融和机械消融技术正被探索作为局部肿瘤的器官保留治疗方案或作为全身性治疗的辅助手段。

关键的颠覆性趋势和技术进步将加速聚焦超音波消融术的临床应用，转变治疗路径，并改变该领域的竞争格局。

聚焦超音波消融领域正经历变革性的转变，这主要得益于技术进步、临床证据的不断累积以及医疗服务体系所面临的压力。成像精度的提高和即时温度测量的改进增强了操作者的信心，使得该技术得以从单一适应症的试点研究扩展到多学科联合计画。同时，模组化系统结构和可携式配置缩小了手术空间，提高了手术效率，从而支持了向门诊模式的过渡。在神经病学领域，更精确的标靶演算法和神经导航工具的整合正在拓展运动障碍的适应症，使其不再局限于自发性震颤。同时，肿瘤科团队正在尝试将消融疗法与免疫调节疗法结合的联合治疗。

2025年关税调整如何重塑聚焦超音波设备相关人员的全球供应链、资本配置决策与采购风险评估

美国将于2025年实施的关税调整，将为聚焦超音波技术领域的製造商、经销商和医疗服务提供者带来更复杂的商业环境。关税调整提高了进口零件和整机的到岸成本，尤其是高精度换能器组件、高频电子元件以及某些通常从全球供应商采购的成像子系统。因此，製造商被迫重新评估其供应链结构，优先考虑在地采购策略，并与供应商协商能够降低成本波动的合约。

一个分层细分框架，用于识别临床适应症、指导技术、临床环境、工作流程、系统结构和患者人口统计特征如何定义差异化的价值提案。

我们的细分市场分析表明，聚焦超音波消融技术与广泛的临床应用、引导技术、医疗环境、工作流程、硬体架构和患者群体交织，从而为每个细分市场创造了差异化的价值提案。神经内科涵盖脑肿瘤治疗、癫痫控制、自发性震颤缓解和帕金森氏症症状控制。肿瘤科涵盖肾癌、肝癌、胰臟癌和前列腺癌的标靶治疗。泌尿科治疗良性前列腺增生和肾结石，而泌尿系统专注于子宫肌腺症和子宫肌瘤。从技术面来看，MRI引导系统分为封闭式和开放式两种配置，分别着重于不同的影像权衡。超音波引导系统根据入路方式和聚焦超音波需求，区分腔内和体外两种方法。最终使用者细分包括医院所属和独立的门诊手术中心、包括公立和私立医院在内的各类医院，以及由学术机构和私人公司组成的研究机构。每个医疗机构都有其自身的资本投资核准流程和临床试验要求。住院和门诊病人工作流程的差异（门诊又细分为日间手术和诊室手术）会影响设备选择、手术室设计和人员配置模式。多元素架构和单元素架构之间的系统类型差异会影响成本、焦点控制和临床适应性。此外，患者年龄层划分区分成人和儿童，成人患者进一步细分为老年和非老年患者，反映了不同的合併症情况和手术全期耐受性。了解这些相互交织的层面有助于更精准的临床定位、客製化的培训计划以及反映每种临床和营运环境细微需求的报销策略。

区域医疗保健基础设施、报销途径和生产策略如何推动美洲、欧洲、中东和非洲以及亚太地区不同的采用模式

区域趋势正在影响聚焦超音波消融系统的采用、资金筹措和应用规模。在美洲，对门诊医疗基础设施的投资以及对微创替代方案日益增长的需求，正推动医院系统和日间手术中心试点开展整合计画。密集的私人医疗机构网路正在支持该手术在大都会圈市场的快速普及。欧洲、中东和非洲的情况则较为复杂，监管协调、公立医院采购週期以及不同的报销政策都会影响该手术的普及速度。在一些国家，集中化的卫生技术评估流程和国家临床网络正在加速实证医学证据的产生和传播。在亚太地区，手术量的成长、私立医院容量的扩大以及积极的本地化生产倡议是强劲成长要素，部分市场优先考虑技术转移和国内生产以应对成本压力。

策略竞争措施、临床伙伴关係模式和服务生态系统决定了市场领导地位和供应商与医疗服务提供者之间的长期关係。

聚焦超音波消融领域的竞争力取决于临床证据的领先地位、系统的多功能性、完善的服务和培训体係以及商业性伙伴关係关係。领先的製造商致力于建立强大的临床试验管线，以证明其在多种适应症中的安全性和有效性，同时投资于模组化硬体和软体升级，从而在无需更换整个系统的情况下逐步提升功能。与影像设备供应商和学术机构的策略联盟正在加速真实世界数据的收集，并为研究者发起的、能够为指南制定提供主导的研究铺平道路。

製造商、临床专案经理和支付方为加速产品推广、确保采购和降低供应链风险而必须采取的实际策略措施

行业领导者应采取一系列合作措施，将临床潜力转化为永续的商业性成功。首先，将产品蓝图与优先临床应用案例相匹配，集中研发资源于能够显着降低医院资源利用率并改善以患者为中心的治疗效果的适应症。其次，投资于可扩展的培训课程和指导项目，以降低社区医院和门诊手术中心采用该产品的门槛，同时收集手术数据以检验疗效。第三，透过多元化采购来源、认证本地供应商以及增加备件库存来增强供应链韧性，从而最大限度地减少贸易政策变化对临床营运的干扰。第四，发展灵活的商业模式，包括资本租赁、按绩效付费合约和综合服务包，以满足公立和私立医院的采购需求。

我们采用了严谨的混合调查方法，结合了相关人员访谈、临床证据综合、供应链映射和交叉检验，以支持可操作的策略指导。

本分析的调查方法结合了与关键相关人员的直接对话、结构化的二手检验综合和三角验证，以确保其稳健的有效性和相关性。主要研究包括对神经内科、肿瘤科、泌尿系统和妇科的临床负责人进行深度访谈；与门诊手术中心和医院的采购和运营总监进行讨论；以及咨询监管和报销专家，以了解区域决策框架。二手研究涵盖了同行评审的临床文献、临床试验註册资讯、医疗设备标籤和审批文件、专利申请以及行业媒体关于策略联盟和产品发布的报告。供应链评估整合了供应商分布图、进口关税和分销模式，以识别潜在的瓶颈和缓解策略。

整合临床、商业性和营运方面的决定因素，以确定聚焦超音波消融术能否充分发挥其潜力，从而改变手术医学的实施方式。

聚焦超音波消融术正处于临床成熟度和商业性可行性交会的转折点，为医疗系统提供了一条降低手术创伤、提高患者周转率的途径。神经内科、肿瘤科、泌尿系统和妇科等领域的推广应用，得益于影像导引、换能器技术以及门诊友善手术流程的不断改进。然而，其广泛应用将受到许多实际因素的影响，例如设备互通性、临床医生培训、报销机制以及在贸易政策变化下供应链的韧性。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 按技术分類的聚焦超音波消融手术市场

  • 磁共振引导
    • 封闭式
    • 开放型
  • 超音波引导
    • 管腔内
    • 体外

9. 依工作流程分類的聚焦超音波消融手术市场

  • 住院病人
  • 门诊
    • 日间手术
    • 门诊手术

第十章 依系统类型分類的聚焦超音波消融手术市场

  • 多元素
  • 单元素

第十一章 依患者年龄层分類的聚焦超音波消融手术市场

  • 成人版
    • 老年人
    • 非老年人
  • 儿童

第十二章 聚焦超音波消融手术市场（依应用领域划分）

  • 神经病学
    • 脑肿瘤
    • 癫痫
    • 自发性震颤
    • 帕金森氏症
  • 肿瘤学
    • 肾癌
    • 肝癌
    • 胰臟癌
    • 摄护腺癌
  • 泌尿系统
    • 良性摄护腺增生
    • 肾结石
  • 妇科领域
    • 子宫肌腺症
    • 子宫肌瘤

第十三章 聚焦超音波消融手术市场（依最终用户划分）

  • 门诊手术中心
    • 医院所属中心
    • 独立中心
  • 医院
    • 私立医院
    • 公立医院
  • 研究所
    • 学术机构
    • 私立机构

14. 各地区聚焦超音波消融手术市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 聚焦超音波消融手术市场（按组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国聚焦超音波消融手术市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国聚焦超音波消融手术市场

第十八章：中国聚焦超音波消融手术市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Alpinion Medical Systems Co Ltd
  • Blatek Industries Inc
  • Boston Scientific Corporation
  • Changjiangyuan Technology Development Co Ltd
  • Chongqing Haifu Medical Equipment Co., Ltd.
  • EDAP TMS SA
  • FUS Foundation
  • GE HealthCare Technologies Inc
  • HistoSonics, Inc.
  • Hitachi, Ltd.
  • Hologic Inc
  • Image Guided Therapy SA
  • Insightec Ltd.
  • Koninklijke Philips NV
  • Medtronic plc
  • Profound Medical Corp.
  • Samsung Medison Co Ltd
  • Shanghai A&S Technology Development Co Ltd
  • Siemens Healthineers AG
  • Sonablate Corp
  • SonaCare Medical LLC
  • Supersonic Imagine SA
  • Theraclion SA
  • Thermogrid Technologies Inc
  • Wikkon Medical Technology Co Ltd
  • ZONARE Medical Systems Inc
Product Code: MRR-C36616F69ABB

The Focused Ultrasound Ablation Surgery Market was valued at USD 3.01 billion in 2025 and is projected to grow to USD 3.26 billion in 2026, with a CAGR of 9.84%, reaching USD 5.81 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.01 billion
Estimated Year [2026] USD 3.26 billion
Forecast Year [2032] USD 5.81 billion
CAGR (%) 9.84%

How the evolution of image-guided energy delivery and clinical protocols is reshaping adoption pathways for focused ultrasound ablation across specialty care settings

Focused ultrasound ablation has evolved from experimental interventions to an increasingly mainstream therapeutic modality across multiple clinical specialties. The technology couples precise energy delivery with image guidance to create noninvasive or minimally invasive tissue ablation, and its clinical promise lies in reducing perioperative morbidity, shortening recovery times, and enabling outpatient care pathways. In neurology, thermal ablation and neuromodulation approaches are being refined to target deep brain structures with millimetric precision for movement disorders and refractory epilepsy. In oncology, thermal and mechanical ablation techniques are being explored as organ-preserving alternatives or adjuncts to systemic therapy for focal tumors.

Concurrently, advances in imaging and transducer design have expanded procedural safety and expanded indications. The convergence of improved guidance platforms, enhanced thermal monitoring, and shorter procedural footprints is enabling broader adoption by hospitals, ambulatory surgical centers, and research institutes. Moreover, the maturation of standardized clinical protocols and the accumulation of medium-term outcome data have begun to shape payer conversations and hospital investment decisions. As clinicians and administrators weigh capital and operational choices, implementation strategies that align technology capability with institutional workflow and patient selection criteria are becoming paramount, guiding how programs scale and integrate focused ultrasound into standard care.

Key disruptive trends and technological improvements that are accelerating clinical adoption, altering care pathways, and shifting competitive imperatives in focused ultrasound ablation

The landscape for focused ultrasound ablation is undergoing transformative shifts driven by technological refinement, clinical evidence accumulation, and systemic pressures on healthcare delivery. Improved imaging fidelity and real-time thermometry have increased operator confidence, enabling expansion from single-indication pilots to multi-specialty programs. At the same time, modular system architectures and portable configurations are reducing procedural footprint and enabling greater procedural throughput, which in turn supports outpatient migration. In neurology, the refinement of targeting algorithms and the integration of neuro-navigation tools have broadened suitability for movement disorders beyond essential tremor, while oncology teams are experimenting with combination regimens that pair ablation with immunomodulatory approaches.

Parallel forces are influencing commercial dynamics. Providers are prioritizing capital that supports ambulatory and hybrid care models, creating demand for devices that demonstrate efficient workflow integration and predictable operating profiles. Research institutes and private centers are catalyzing adoption by generating comparative effectiveness evidence and hosting investigator-initiated studies. Finally, the shifting reimbursement landscape and greater emphasis on value-based outcomes are privileging technologies that demonstrably reduce length of stay, lower complication rates, and enable same-day discharge, thereby accelerating adoption in resource-constrained care environments.

How 2025 tariff adjustments are reshaping global supply chains, capital deployment decisions, and procurement risk assessments for focused ultrasound device stakeholders

United States tariff changes introduced in 2025 have created a more complex commercial environment for manufacturers, distributors, and healthcare providers engaged with focused ultrasound technologies. Tariff adjustments have increased landed costs for imported components and finished systems, particularly for high-precision transducer assemblies, RF electronics, and certain imaging subsystems that are commonly sourced from global suppliers. As a result, manufacturers have been prompted to reassess supply chain structures, prioritize local content strategies, and negotiate supplier agreements that mitigate cost volatility.

Clinicians and hospital procurement teams have felt downstream effects through extended lead times and periodic component shortages, which have in some instances delayed installation timelines for capital equipment. Moreover, the tariff environment has sharpened attention on total cost of ownership, including service contracts and consumable pricing, which influences procurement committees' vendor selection criteria. In response, several device makers have expanded regional repair centers, increased local inventory buffers, and accelerated partnerships with domestic suppliers to preserve pricing competitiveness and protect clinical uptime. These adaptive measures, together with proactive contracting strategies by providers, are serving to reduce disruption while reshaping how organizations evaluate vendor resilience and long-term partnership value.

A layered segmentation framework revealing how clinical indication, guidance technology, care setting, workflow, system architecture, and patient demographics define differentiated value propositions

Segmentation analysis reveals that focused ultrasound ablation technologies intersect a broad matrix of clinical applications, guidance modalities, care settings, workflows, hardware architectures, and patient populations, creating differentiated value propositions for each market segment. Within applications, neurology spans brain tumor management, epilepsy control, essential tremor relief, and Parkinson disease symptom modulation, while oncology encompasses focal treatments for kidney, liver, pancreatic, and prostate cancers. Urology applications address benign prostatic hyperplasia and kidney stones, and women's health focuses on adenomyosis and uterine fibroids. From a technology perspective, MRI-guided systems bifurcate into closed bore and open bore configurations that prioritize different imaging trade-offs, and ultrasound-guided systems differentiate between endoluminal and extracorporeal approaches based on access and focal depth requirements. End user segmentation includes ambulatory surgical centers that may be hospital-owned or standalone, hospitals that include private and public institutions, and research institutes composed of academic and private entities, each with distinct capital approval processes and clinical trial imperatives. Workflow distinctions between inpatient and outpatient care, with outpatient further subdivided into daycare surgery and office-based surgery, influence device selection, room design, and staffing models. System type considerations between multi-element and single-element architectures drive cost, focal control, and clinical versatility. Finally, patient age group segmentation differentiates adult and pediatric populations, with adult care further stratified by elderly and non-elderly cohorts to reflect differing comorbidity profiles and perioperative tolerance. Understanding these intersecting layers enables more precise clinical positioning, tailored training programs, and reimbursement strategies that reflect the nuanced needs of each clinical and operational context.

How regional healthcare infrastructure, reimbursement pathways, and manufacturing strategies are driving differentiated adoption patterns across the Americas, Europe Middle East & Africa, and Asia-Pacific

Regional dynamics are shaping where and how focused ultrasound ablation systems are adopted, funded, and scaled. In the Americas, investment in outpatient infrastructure and a growing appetite for minimally invasive alternatives have incentivized hospital systems and ambulatory surgery centers to pilot integrated programs, while a dense private provider network supports rapid procedural diffusion across metropolitan markets. Europe, the Middle East & Africa present a heterogeneous landscape where regulatory harmonization, public hospital procurement cycles, and variable reimbursement policies influence adoption tempo; in several countries, centralized health technology assessment processes and national clinical networks have accelerated evidence generation and dissemination. Asia-Pacific exhibits strong growth drivers tied to rising procedural volumes, expanding private hospital capacity, and proactive local manufacturing initiatives, with some markets prioritizing technology transfer and domestic production to manage cost pressures.

Across regions, common themes emerge: the need for context-specific training pathways, the importance of aligning device capabilities with facility workflows, and the value of robust clinical evidence to support reimbursement negotiations. Consequently, successful regional strategies anticipate regulatory timelines, invest in local key opinion leader engagement, and design distribution models that reflect the operational realities of hospitals, ambulatory centers, and research institutes in each geography.

Strategic competitive behaviors, clinical partnership models, and service ecosystems that determine market leadership and long-term vendor-institution relationships

Competitive dynamics in focused ultrasound ablation are defined by a combination of clinical evidence leadership, system versatility, service and training ecosystems, and commercial partnerships. Leading manufacturers have focused on building robust clinical pipelines that demonstrate safety and efficacy across multiple indications, while also investing in modular hardware and software upgrades that enable incremental capability expansion without full-system replacement. Strategic alliances with imaging vendors and academic centers have accelerated real-world data collection and created pathways for investigator-initiated studies that inform guideline development.

Service models have become a competitive differentiator; organizations that combine device sales with comprehensive training programs, local maintenance networks, and outcome tracking platforms are more likely to secure long-term institutional partnerships. Additionally, aftermarket revenue streams from consumables, software licenses, and procedure-specific disposables are increasingly important to financial models. Partnerships between device manufacturers and hospital networks or ambulatory surgical groups have also emerged, facilitating pilot programs and bundled purchasing agreements. Finally, intellectual property portfolios and regulatory track records matter: companies with cleared device claims across multiple indications and geographies can leverage those credentials to accelerate adoption and negotiate favorable procurement terms with large health systems.

Actionable strategic imperatives for manufacturers, clinical program leaders, and payers to accelerate adoption, secure procurement, and de-risk supply chain exposure

Industry leaders should pursue a set of coordinated actions to convert clinical promise into sustainable commercial performance. First, align product roadmaps with prioritized clinical use cases by concentrating development resources on indications that offer clear reductions in hospital resource utilization and improved patient-centric outcomes. Second, invest in scalable training curricula and proctoring programs that lower the adoption barrier for community hospitals and ambulatory surgical centers, while simultaneously capturing procedural data for outcomes validation. Third, strengthen supply chain resilience by diversifying sourcing, qualifying regional suppliers, and increasing spare parts inventories to minimize clinical disruptions from trade policy shifts. Fourth, develop flexible commercial models that include capital leases, outcome-based contracting, and bundled service packages to address procurement preferences across public and private hospitals.

Moreover, foster payer engagement early by generating cost-effectiveness evidence and real-world outcome datasets that demonstrate reduced length of stay and complication rates. Engage in targeted regional strategies by partnering with local manufacturing or service providers where tariffs or logistic challenges pressure total cost of ownership. Finally, prioritize interoperability and software-driven service offerings that enable remote monitoring, predictive maintenance, and outcomes tracking, thereby creating recurring revenue streams and deepening client relationships.

A rigorous mixed-method research approach combining stakeholder interviews, clinical evidence synthesis, supply chain mapping, and cross-validation to support actionable strategic guidance

The research methodology underpinning this analysis combined primary stakeholder engagement with structured secondary evidence synthesis and triangulation to ensure robustness and relevance. Primary research included in-depth interviews with clinical leaders across neurology, oncology, urology, and women's health, discussions with procurement and operations executives from ambulatory surgical centers and hospitals, and consultations with regulatory and reimbursement specialists to understand regional decision frameworks. Secondary research encompassed peer-reviewed clinical literature, clinical trial registries, device labeling and clearance documents, patent filings, and industry press that highlights strategic partnerships and product launches. Supply chain assessments integrated supplier mapping, import tariff schedules, and distributor models to identify potential bottlenecks and mitigation pathways.

Data were synthesized using a cross-validation approach that reconciled clinician perspectives, commercial intelligence, and regulatory context. Where evidence gaps existed, scenario-based analysis was used to articulate plausible operational impacts and strategic responses. The methodology prioritized transparency, noting the provenance of primary insights and the limitations of indirect evidence, and emphasized actionable conclusions designed to inform procurement decisions, clinical program design, and strategic investment prioritization.

Synthesis of clinical, commercial, and operational determinants that will govern whether focused ultrasound ablation fulfills its potential to transform procedural care delivery

Focused ultrasound ablation stands at an inflection point where clinical maturity and commercial viability intersect, offering health systems a pathway to reduce procedural invasiveness and enhance patient throughput. The technology's expansion across neurology, oncology, urology, and women's health is supported by iterative improvements in imaging guidance, transducer technology, and procedural workflows that favor outpatient care. Nevertheless, adoption will be mediated by pragmatic considerations including device interoperability, clinician training, reimbursement alignment, and supply chain resilience in the face of trade policy shifts.

Strategic success will accrue to organizations that align product development with high-value clinical use cases, invest in scalable training and service ecosystems, and engage payers with robust real-world evidence. Regional strategies that account for regulatory heterogeneity and manufacturing localization will further reduce procurement friction. In short, focused ultrasound ablation can meaningfully alter clinical pathways and institutional economics, but realizing that potential requires coordinated action across clinical, commercial, and operational dimensions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Focused Ultrasound Ablation Surgery Market, by Technology

  • 8.1. Mri Guided
    • 8.1.1. Closed Bore
    • 8.1.2. Open Bore
  • 8.2. Ultrasound Guided
    • 8.2.1. Endoluminal
    • 8.2.2. Extracorporeal

9. Focused Ultrasound Ablation Surgery Market, by Workflow

  • 9.1. Inpatient
  • 9.2. Outpatient
    • 9.2.1. Daycare Surgery
    • 9.2.2. Office Based Surgery

10. Focused Ultrasound Ablation Surgery Market, by System Type

  • 10.1. Multi Element
  • 10.2. Single Element

11. Focused Ultrasound Ablation Surgery Market, by Patient Age Group

  • 11.1. Adult
    • 11.1.1. Elderly
    • 11.1.2. Non Elderly
  • 11.2. Pediatric

12. Focused Ultrasound Ablation Surgery Market, by Application

  • 12.1. Neurology
    • 12.1.1. Brain Tumor
    • 12.1.2. Epilepsy
    • 12.1.3. Essential Tremor
    • 12.1.4. Parkinson Disease
  • 12.2. Oncology
    • 12.2.1. Kidney Cancer
    • 12.2.2. Liver Cancer
    • 12.2.3. Pancreatic Cancer
    • 12.2.4. Prostate Cancer
  • 12.3. Urology
    • 12.3.1. Benign Prostatic Hyperplasia
    • 12.3.2. Kidney Stones
  • 12.4. Women Health
    • 12.4.1. Adenomyosis
    • 12.4.2. Uterine Fibroids

13. Focused Ultrasound Ablation Surgery Market, by End User

  • 13.1. Ambulatory Surgical Centers
    • 13.1.1. Hospital Owned Centers
    • 13.1.2. Standalone Centers
  • 13.2. Hospitals
    • 13.2.1. Private Hospitals
    • 13.2.2. Public Hospitals
  • 13.3. Research Institutes
    • 13.3.1. Academic Institutes
    • 13.3.2. Private Institutes

14. Focused Ultrasound Ablation Surgery Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Focused Ultrasound Ablation Surgery Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Focused Ultrasound Ablation Surgery Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Focused Ultrasound Ablation Surgery Market

18. China Focused Ultrasound Ablation Surgery Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Alpinion Medical Systems Co Ltd
  • 19.6. Blatek Industries Inc
  • 19.7. Boston Scientific Corporation
  • 19.8. Changjiangyuan Technology Development Co Ltd
  • 19.9. Chongqing Haifu Medical Equipment Co., Ltd.
  • 19.10. EDAP TMS S.A.
  • 19.11. FUS Foundation
  • 19.12. GE HealthCare Technologies Inc
  • 19.13. HistoSonics, Inc.
  • 19.14. Hitachi, Ltd.
  • 19.15. Hologic Inc
  • 19.16. Image Guided Therapy S.A.
  • 19.17. Insightec Ltd.
  • 19.18. Koninklijke Philips N.V.
  • 19.19. Medtronic plc
  • 19.20. Profound Medical Corp.
  • 19.21. Samsung Medison Co Ltd
  • 19.22. Shanghai A&S Technology Development Co Ltd
  • 19.23. Siemens Healthineers AG
  • 19.24. Sonablate Corp
  • 19.25. SonaCare Medical LLC
  • 19.26. Supersonic Imagine SA
  • 19.27. Theraclion S.A.
  • 19.28. Thermogrid Technologies Inc
  • 19.29. Wikkon Medical Technology Co Ltd
  • 19.30. ZONARE Medical Systems Inc

LIST OF FIGURES

  • FIGURE 1. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WORKFLOW, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY SYSTEM TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY MRI GUIDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY MRI GUIDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY MRI GUIDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY MRI GUIDED, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY CLOSED BORE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY CLOSED BORE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY CLOSED BORE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY OPEN BORE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY OPEN BORE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY OPEN BORE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ULTRASOUND GUIDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ULTRASOUND GUIDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ULTRASOUND GUIDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ENDOLUMINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ENDOLUMINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ENDOLUMINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY EXTRACORPOREAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY EXTRACORPOREAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY EXTRACORPOREAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY INPATIENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY INPATIENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY INPATIENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY OUTPATIENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY OUTPATIENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY OUTPATIENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY OUTPATIENT, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY DAYCARE SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY DAYCARE SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY DAYCARE SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY OFFICE BASED SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY OFFICE BASED SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY OFFICE BASED SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY MULTI ELEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY MULTI ELEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY MULTI ELEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY SINGLE ELEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY SINGLE ELEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY SINGLE ELEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ELDERLY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ELDERLY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ELDERLY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY NON ELDERLY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY NON ELDERLY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY NON ELDERLY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY BRAIN TUMOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY BRAIN TUMOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY BRAIN TUMOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY EPILEPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY EPILEPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ESSENTIAL TREMOR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ESSENTIAL TREMOR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ESSENTIAL TREMOR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PARKINSON DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PARKINSON DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PARKINSON DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY KIDNEY CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY KIDNEY CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY KIDNEY CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY LIVER CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY LIVER CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY LIVER CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PANCREATIC CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PANCREATIC CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PANCREATIC CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PROSTATE CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY UROLOGY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY KIDNEY STONES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY KIDNEY STONES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY KIDNEY STONES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WOMEN HEALTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WOMEN HEALTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WOMEN HEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WOMEN HEALTH, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ADENOMYOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ADENOMYOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ADENOMYOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY UTERINE FIBROIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY UTERINE FIBROIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY UTERINE FIBROIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY HOSPITAL OWNED CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY HOSPITAL OWNED CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY HOSPITAL OWNED CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY STANDALONE CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY STANDALONE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY STANDALONE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ACADEMIC INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ACADEMIC INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PRIVATE INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PRIVATE INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PRIVATE INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY MRI GUIDED, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 148. AMERICAS FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY OUTPATIENT, 2018-2032 (USD MILLION)
  • TABLE 149. AMERICAS FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. AMERICAS FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 151. AMERICAS FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 152. AMERICAS FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. AMERICAS FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. AMERICAS FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 155. AMERICAS FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY UROLOGY, 2018-2032 (USD MILLION)
  • TABLE 156. AMERICAS FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WOMEN HEALTH, 2018-2032 (USD MILLION)
  • TABLE 157. AMERICAS FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. AMERICAS FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 159. AMERICAS FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 160. AMERICAS FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY MRI GUIDED, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY OUTPATIENT, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY UROLOGY, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WOMEN HEALTH, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY MRI GUIDED, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY OUTPATIENT, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY UROLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WOMEN HEALTH, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 194. LATIN AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 196. LATIN AMERICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY MRI GUIDED, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY OUTPATIENT, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY UROLOGY, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WOMEN HEALTH, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPE FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPE FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY MRI GUIDED, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPE FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY OUTPATIENT, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPE FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY UROLOGY, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WOMEN HEALTH, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPE FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPE FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 234. MIDDLE EAST FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY MRI GUIDED, 2018-2032 (USD MILLION)
  • TABLE 236. MIDDLE EAST FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 238. MIDDLE EAST FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY OUTPATIENT, 2018-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. MIDDLE EAST FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 242. MIDDLE EAST FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 244. MIDDLE EAST FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY UROLOGY, 2018-2032 (USD MILLION)
  • TABLE 246. MIDDLE EAST FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WOMEN HEALTH, 2018-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. MIDDLE EAST FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 250. MIDDLE EAST FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 251. AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 252. AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 253. AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY MRI GUIDED, 2018-2032 (USD MILLION)
  • TABLE 254. AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2032 (USD MILLION)
  • TABLE 255. AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 256. AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY OUTPATIENT, 2018-2032 (USD MILLION)
  • TABLE 257. AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 259. AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 260. AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 261. AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 262. AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 263. AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY UROLOGY, 2018-2032 (USD MILLION)
  • TABLE 264. AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WOMEN HEALTH, 2018-2032 (USD MILLION)
  • TABLE 265. AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 267. AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 268. AFRICA FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY MRI GUIDED, 2018-2032 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ULTRASOUND GUIDED, 2018-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WORKFLOW, 2018-2032 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY OUTPATIENT, 2018-2032 (USD MILLION)
  • TABLE 275. ASIA-PACIFIC FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. ASIA-PACIFIC FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ADULT, 2018-2032 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
  • TABLE 281. ASIA-PACIFIC FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY UROLOGY, 2018-2032 (USD MILLION)
  • TABLE 282. ASIA-PACIFIC FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY WOMEN HEALTH, 2018-2032 (USD MILLION)
  • TABLE 283. ASIA-PACIFIC FOCUSED ULTRASOUND ABLATION SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 284.